Hepatic stellate cells remodel liver-resident CD8+ T cells and constrain immunosurveillance
The liver constitutes a distinct immunological niche in which CD8+ T cells balance immune protection and tissue integrity. How chronic liver disease (CLD) remodels human liver–resident CD8+ T cells remains poorly understood. We demonstrate that activated hepatic stellate cells (HSCs) create immunoinstructive fibrotic niches that regulate liver-resident CD8+ T cell differentiation, localization, and function. CD103-expressing liver-resident CD8+ T cells accumulate with increasing fibrosis severity and preferentially localize within collagen-rich scar tissue. HSC-derived and matrix-retained TGFβ promote acquisition of a residency program characterized by upregulation of CD103, ECM-binding integrins, and adhesion molecules. Despite their increased abundance, liver-resident CD8+ T cells in CLD exhibit impaired antigen-dependent effector function, increased inhibitory receptor expression, and a transcriptional program associated with T cell dysfunction. Importantly, responses to PMA/ionomycin remain intact, indicating preserved effector competence. Mechanistically, HSCs directly suppress antigen-specific liver-resident CD8+ T cell function, with partial restoration following PD-L1/PD-L2 blockade. These findings identify the fibrotic niche as a central regulator of liver-resident CD8+ T cells and reveal how fibrosis can limit local immunosurveillance.
Authors
- Bethany H. James (ORCID: https://orcid.org/0009-0005-1937-6184)
- Scott P Davies (ORCID: https://orcid.org/0000-0001-6899-1339)
- Juliet Luft (ORCID: https://orcid.org/0000-0003-2458-9377)
- Prakash Ramachandran (ORCID: https://orcid.org/0000-0001-5996-2413)
- Keshav Rao (ORCID: https://orcid.org/0009-0005-3525-6385)
- Ginevra Pistocchi (ORCID: https://orcid.org/0009-0004-7749-785X)
- Andrew Rennie Hall (ORCID: https://orcid.org/0000-0001-5733-9484)
- Krista Rombouts (ORCID: https://orcid.org/0000-0001-9440-0571)
- Anandita Mathur (ORCID: https://orcid.org/0009-0007-2542-7122)
- Stephanie Kucykowicz (ORCID: https://orcid.org/0000-0002-8849-218X)
- Giulia Lupo (ORCID: https://orcid.org/0000-0002-8227-5061)
- Brian Ritchie Davidson (ORCID: https://orcid.org/0000-0002-9152-5907)
- Maria Castanho Martins (ORCID: https://orcid.org/0009-0007-8421-8814)
- George E. Finney (ORCID: https://orcid.org/0000-0002-4230-4235)
- Massimo Pinzani (ORCID: https://orcid.org/0000-0003-1398-1541)
- Walid Al‐Akkad (ORCID: https://orcid.org/0000-0002-0109-3021)
- Mala K. Maini (ORCID: https://orcid.org/0000-0001-6384-1462)
- Alberto Quaglia (ORCID: https://orcid.org/0000-0002-3333-3579)
- Laura J. Pallett (ORCID: https://orcid.org/0000-0002-4161-9462)
- Niamah A. Nishan (ORCID: https://orcid.org/0009-0006-1831-1415)
Institutions
- Royal Free London NHS Foundation Trust (GB)
- NIHR Birmingham Liver Biomedical Research Unit (GB)
- Centre for Inflammation Research (GB)
- Institute of Infection and Immunity (CA)
- University College London (GB)
- University of Birmingham (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- The Journal of Experimental Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1084/jem.20261316
- Citations
- 1
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 2.07
Funders
- Government of the United Kingdom
- UK Research and Innovation
- University College London
- HORIZON EUROPE Framework Programme